Investors Are Digesting These 4 Stock Earnings Insights

Brookdale Senior Living Inc. (NYSE:BKD) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.04 in the quarter versus EPS of $-0.15 in the year-earlier quarter. Revenue Rose 3.11% to $712.27 million from the year-earlier quarter.

Brookdale Senior Living Inc. reported adjusted EPS loss of $0.04 per share. By that measure, the company missed the mean analyst estimate of $0.01. It beat the average revenue estimate of $700.85 million.

BKD 20130811

Hansen Medical, Inc. (NASDAQ:HNSN) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $-0.2 in the quarter versus EPS of $-0.19 in the year-earlier quarter. Revenue Decreased 5.65% to $3.34 million from the year-earlier quarter.

Hansen Medical, Inc. reported adjusted EPS loss of $0.2 per share. By that measure, the company missed the mean analyst estimate of $-0.16. It missed the average revenue estimate of $3.35 million.

HNSN 20130811

Halozyme Therapeutics, Inc. (NASDAQ:HALO) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.2 in the quarter versus EPS of $-0.13 in the year-earlier quarter. Revenue Rose 87.24% to $14.53 million from the year-earlier quarter.

Halozyme Therapeutics, Inc. reported adjusted EPS loss of $0.2 per share. By that measure, the company missed the mean analyst estimate of $-0.13. It beat the average revenue estimate of $11.29 million.

HALO 20130811

BIOLASE (NASDAQ:BIOL) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share were the same at $-0.06 in the quarter as EPS of $-0.06 in the year-earlier quarter. Revenue Rose 6.61% to $14.2 million from the year-earlier quarter.

BIOLASE reported adjusted EPS loss of $0.06 per share. By that measure, the company missed the mean analyst estimate of $-0.04. It missed the average revenue estimate of $15.69 million.

BIOL 20130811

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.